146 related articles for article (PubMed ID: 10451795)
61. Technetium-99m-MAG3 versus iodine-123-OIH: renal clearance and distribution volume as measured by a constant infusion technique.
Prenen JA; de Klerk JM; van het Schip AD; van Rijk PP
J Nucl Med; 1991 Nov; 32(11):2057-60. PubMed ID: 1834812
[TBL] [Abstract][Full Text] [Related]
62. A comparative study of renal scintigraphy and clearance with technetium-99m-MAG3 and iodine-123-hippurate in patients with renal disorders.
Müller-Suur R; Bois-Svensson I; Mesko L
J Nucl Med; 1990 Nov; 31(11):1811-7. PubMed ID: 2146371
[TBL] [Abstract][Full Text] [Related]
63. Optimum sample times for single-injection, multisample renal clearance methods.
Russell CD
J Nucl Med; 1993 Oct; 34(10):1761-5. PubMed ID: 8410295
[TBL] [Abstract][Full Text] [Related]
64. [A study of renal leak of 99mTc-DMSA in maleate-treated rats by factor analysis].
Koide H; Yonekura Y; Konishi J
Kaku Igaku; 1990 Feb; 27(2):139-42. PubMed ID: 2161473
[TBL] [Abstract][Full Text] [Related]
65. 99mTc-2,3-diaminopropionic acid complex as renal function agent: comparison of biological properties with 99mTc-DTPA and 131I-OIH.
Chattopadhyay M; Jalan KN; Pal AK; Banerjee SN
Int J Rad Appl Instrum B; 1987; 14(6):599-604. PubMed ID: 3323136
[TBL] [Abstract][Full Text] [Related]
66. [A comparison of different methods of calculating clearances using 99mTc-mercaptoacetyltriglycine and 123I- or 131I-ortho-iodohippuric acid].
Keske U; Cordes M; Hosten N; Roll D; Hunger J; Felix R
Nuklearmedizin; 1990 Jun; 29(3):93-100. PubMed ID: 2144045
[TBL] [Abstract][Full Text] [Related]
67. Preliminary results comparing the extraction efficiencies of 131I-OIH and 99mTc-MAG3 in rat models of ischemia, renal artery stenosis, and ciclosporin toxicity.
Taylor A; Greene J; Eshima D; Dillehay D
Contrib Nephrol; 1990; 79():21-3. PubMed ID: 2146084
[No Abstract] [Full Text] [Related]
68. Technetium-99m-L,L-ethylenedicysteine renal scan as a single-modality investigation for the evaluation of renal morphology and function: a comparative study with technetium-99m-dimercaptosuccinic acid.
Narayana C; Tripathi M; Kumar A; Gowda NK; Phom H; Chandra P; Bandopadhyaya G; Bal C
Nucl Med Commun; 2004 Jul; 25(7):743-7. PubMed ID: 15208504
[TBL] [Abstract][Full Text] [Related]
69. Determination of glomerular filtration rate using technetium-99m-DTPA with differing degrees of renal function.
Morton KA; Pisani DE; Whiting JH; Cheung AK; Arias JM; Valdivia S
J Nucl Med Technol; 1997 Jun; 25(2):110-4. PubMed ID: 9239614
[TBL] [Abstract][Full Text] [Related]
70. Reproducibility of technetium-99m ethylenedicysteine clearance.
Kabasakal L; Halaç M; Alkan E; Ozçelik N; Uslu I
Eur J Nucl Med; 1999 Aug; 26(8):900-2. PubMed ID: 10436204
[TBL] [Abstract][Full Text] [Related]
71. [Advantages of the new radiopharmaceutic agent, 99mTC-mercaptoacetyltriglycine (99mTc-MAG3), in the diagnosis of kidneydiseases. A comparative study with 131I-OIH, 99mTc-DTPA and 99mTc-DMSA].
Lepej J; Marosová A; Kliment J; Buchanec J; Svitác J; Klisenbauer L
Bratisl Lek Listy; 1992 May; 93(5):258-65. PubMed ID: 1327424
[TBL] [Abstract][Full Text] [Related]
72. Initial Evaluation of (99m)Tc(CO)3(ASMA) as a Renal Tracer in Healthy Human Volunteers.
Lipowska M; Klenc J; Folks RD; Taylor AT
Nucl Med Mol Imaging; 2014 Sep; 48(3):216-24. PubMed ID: 25177379
[TBL] [Abstract][Full Text] [Related]
73. Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.
Taylor A; Ziffer JA; Steves A; Eshima D; Delaney VB; Welchel JD
Radiology; 1989 Mar; 170(3 Pt 1):721-5. PubMed ID: 2521734
[TBL] [Abstract][Full Text] [Related]
74. Comparison of 99Tcm-mercaptoacetyltriglycine and 131I-orthoiodohippurate in determination of effective renal plasma flow (ERPF).
Abdel-Dayem HM; Sadek S; al-Bahar R; Sabha M; el-Sayed M
Nucl Med Commun; 1989 Feb; 10(2):99-107. PubMed ID: 2525236
[TBL] [Abstract][Full Text] [Related]
75. Effect of advanced age on p-aminohippurate-induced inhibition of renal tubular secretion in male Fischer 344 rats.
Galinsky RE; Eshima D; Hansen L; Greene J; Dillehay D; Taylor A
Mech Ageing Dev; 1990 Dec; 56(3):209-22. PubMed ID: 2150974
[TBL] [Abstract][Full Text] [Related]
76. The predictive value of 131I-hippurate clearance in the prognosis of acute renal failure.
Ilic S; Rajic M; Vlajkovic M; Bogicevic M; Stefanovic V
Ren Fail; 2000; 22(5):581-9. PubMed ID: 11041290
[TBL] [Abstract][Full Text] [Related]
77. 99mTc renal tubular function agents: current status.
Eshima D; Fritzberg AR; Taylor A
Semin Nucl Med; 1990 Jan; 20(1):28-40. PubMed ID: 2136959
[TBL] [Abstract][Full Text] [Related]
78. [Clinical evaluation of 99mTc-MAG3 as a radiotracer to assess the function of transplanted kidney: comparison with 123I-OIH].
Yamamoto K; Takahashi N; Sugimoto K; Yoshida M; Hayashi N; Ishii Y; Nishibuchi S; Muranaka K; Okada K; Miyazaki M
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 May; 55(6):409-13. PubMed ID: 7617467
[TBL] [Abstract][Full Text] [Related]
79. Scintigraphic assessment of renal function in steel plant workers occupationally exposed to lead.
Wrońska-Nofer T; Pisarska A; Trzcinka-Ochocka M; Hałatek T; Stetkiewicz J; Braziewicz J; Nofer JR; Wąsowicz W
J Occup Health; 2015; 57(2):91-9. PubMed ID: 25735505
[TBL] [Abstract][Full Text] [Related]
80. The value of different washout parameters in the evaluation of renal transplants by technetium-99m-ethylene- l-l-dicysteine.
Kanmaz B; Sayman HB; Alan N; Devranoglu G; Nisli S; Sonmezoglu K; Kabasakal L; Halac M; Onsel C; Uslu I
Hell J Nucl Med; 2010; 13(2):127-31. PubMed ID: 20808985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
